- Home
- ABNB vs BMY Comparison
ABNB vs BMY Comparison
Compare ABNB & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABNB | BMY |
|---|---|---|
| Founded | 2008 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.3B | 113.5B |
| IPO Year | 2020 | 2006 |
Fundamental Metrics
Financial Performance| Metric | ABNB | BMY |
|---|---|---|
| Price | $166.84 | $62.62 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 30 | 15 |
| Target Price | ★ $151.93 | $61.73 |
| AVG Volume (30 Days) | 3.9M | ★ 6.9M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 4.38% |
| EPS Growth | N/A | ★ 178.46 |
| EPS | N/A | ★ 2.93 |
| Revenue | $12,241,000,000.00 | ★ $48,194,000,000.00 |
| Revenue This Year | $14.25 | N/A |
| Revenue Next Year | $10.05 | N/A |
| P/E Ratio | $30.80 | ★ $21.42 |
| Revenue Growth | ★ 10.26 | N/A |
| 52 Week Low | $110.81 | $42.52 |
| 52 Week High | $193.45 | $68.64 |
Technical Indicators
Market Signals| Indicator | ABNB | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 42.30 | 39.81 |
| Support Level | $126.08 | $56.46 |
| Resistance Level | $187.12 | $68.33 |
| Average True Range (ATR) | 4.15 | 1.17 |
| MACD | -2.31 | -0.51 |
| Stochastic Oscillator | 12.38 | 11.98 |
Price Performance
Historical ComparisonAbout ABNB Airbnb Inc.
Airbnb is the world's largest online alternative accommodation travel agency; it also offers booking services for boutique hotels, experiences, and hotel-like services. Airbnb's platform offers over 9 million active accommodation listings. Listings from the company's 5 million-plus hosts are spread over almost every country in the world. In 2025, 42% of revenue was from North America, 39% from Europe, the Middle East, and Africa, 10% from Latin America, and 9% from Asia-Pacific. Transaction fees for online bookings account for all its revenue.
About BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.